J05 — HCPCS Level II Codes

• J0500 Injection, dicyclomine hcl, up to 20 mg billable
• J0515 Injection, benztropine mesylate, per 1 mg billable
• J0517 Injection, benralizumab, 1 mg billable
• J0520 Injection, bethanechol chloride, myotonachol or urecholine, up to 5 mg billable
• J0525 Injection, cefotetan disodium, 10 mg billable
• J0528 Injection, fosfomycin disodium, 20 mg billable
• J0558 Injection, penicillin g benzathine and penicillin g procaine, 100,000 units billable
• J0561 Injection, penicillin g benzathine, 100,000 units billable
• J0565 Injection, bezlotoxumab, 10 mg billable
• J0567 Injection, cerliponase alfa, 1 mg billable
• J0570 Buprenorphine implant, 74.2 mg billable
• J0571 Buprenorphine, oral, 1 mg billable
• J0572 Buprenorphine/naloxone, oral, less than or equal to 3 mg buprenorphine billable
• J0573 Buprenorphine/naloxone, oral, greater than 3 mg, but less than or equal to 6 mg buprenorphine billable
• J0574 Buprenorphine/naloxone, oral, greater than 6 mg, but less than or equal to 10 mg buprenorphine billable
• J0575 Buprenorphine/naloxone, oral, greater than 10 mg buprenorphine billable
• J0577 Injection, buprenorphine extended-release (brixadi), less than or equal to 7 days of therapy billable
• J0578 Injection, buprenorphine extended release (brixadi), greater than 7 days and up to 28 days of therapy billable
• J0582 Injection, bivalirudin (endo), not therapeutically equivalent to j0583, 1 mg billable
• J0583 Injection, bivalirudin, 1 mg billable
• J0584 Injection, burosumab-twza 1 mg billable
• J0585 Injection, onabotulinumtoxina, 1 unit billable
• J0586 Injection, abobotulinumtoxina, 5 units billable
• J0587 Injection, rimabotulinumtoxinb, 100 units billable
• J0588 Injection, incobotulinumtoxin a, 1 unit billable
• J0589 Injection, daxibotulinumtoxina-lanm, 1 unit billable
• J0591 Injection, deoxycholic acid, 1 mg billable
• J0592 Injection, buprenorphine hydrochloride, 0.1 mg billable
• J0593 Injection, lanadelumab-flyo, 1 mg (code may be used for medicare when drug administered under direct supervision of a physician, not for use when drug is self-administered) billable
• J0594 injection, busulfan, 1 mg billable
• J0595 Injection, butorphanol tartrate, 1 mg billable
• J0596 Injection, c1 esterase inhibitor (recombinant), ruconest, 10 units billable
• J0597 Injection, c-1 esterase inhibitor (human), berinert, 10 units billable
• J0598 Injection, c-1 esterase inhibitor (human), cinryze, 10 units billable
• J0599 Injection, c-1 esterase inhibitor (human), (haegarda), 10 units billable